Pharmacodynamics Study of MRX34, MicroRNA Liposomal Injection in Melanoma Patients With Biopsy Accessible Lesions
Status:
Withdrawn
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
This study is designed to investigate the biomarkers, pharmacodynamics and pharmacokinetics
of the liposomal micro-ribonucleic acid-34 (microRNA-34, miR-34). Melanoma patients with
easily accessible lesions will undergo serial biopsies and serial blood samples will be
collected.